A recent New York Times report describes how initial public offerings of major AI companies could put tens of billions of dollars of new philanthropy into global health.
Many of the new donors are drawn to low-cost, evidence-backed measures — deworming is named among them — but the article also exposes a tension at the heart of this moment:
"These funders tend to have a preoccupation with metrics and results that does not easily graft to the complex work of ending poverty. And as they become some of the most powerful players in the field, the shift could undermine the sovereignty of low-income countries trying to take control of their own health systems after decades of heavy-handed external influence."
Full article